Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details. Federal Register notices are for general information purposes only and should not be relied upon as a substitute for thorough regulatory assessment. All efforts are made to assure the accuracy and completeness of this information, but CHPA cannot guarantee the information. As a benefit of CHPA membership, recipients are asked not to forward or share this information outside of your company.
In a major victory for consumer health, today Mississippi has repealed an 11-year-old law that banned over-the-counter (OTC) sales of certain medicines for colds and allergies containing the decongestant pseudoephedrine (PSE).
On Tuesday, March 9, the Mississippi House voted to repeal the state’s existing ban of over-the-counter (OTC) sales of pseudoephedrine (PSE) on an 117-3 vote. Since 2010, Mississippi has categorized PSE as a schedule III controlled substance.
Recent media reports have cited infectious disease experts who recommend against premedicating with over-the-counter (OTC) pain relievers, like those containing acetaminophen and ibuprofen, when getting a COVID-19 vaccine.